文献速递心脏核医学肿瘤 PET/CT放射性药物与辐射防护

动脉粥样硬化斑块炎症成像:让它变得简单

Imaging inflammation in atherosclerotic plaques: Just make it easy!
PubMed 文献 · J Nucl Cardiol · 2018-04-26

本文综述了动脉粥样硬化斑块炎症的无创成像方法,指出18F-FDG PET是目前评估斑块内活化巨噬细胞密度最广泛使用的技术,但存在后勤和技术限制。作者认为,靶向斑块炎症更特异的放射性示踪剂将大大促进该成像的组织安排,并有助于扩大PET在动脉粥样硬化患者评估中的应用。

要点

  • 18F-FDG PET是目前评估动脉粥样硬化斑块活化巨噬细胞密度最广泛使用的成像技术。
  • FDG-PET成像存在后勤和技术限制,是更广泛用于动脉粥样硬化患者评估的重要障碍。
  • 靶向斑块炎症更特异的放射性示踪剂可大大促进该成像的后勤组织并扩大PET应用。

核心结论

  • 靶向动脉粥样硬化斑块炎症更特异的放射性示踪剂将大大促进该成像的后勤组织,并有助于扩大PET在动脉粥样硬化患者评估中的应用。

研究设计与样本

  • 本文为综述,检索范围原文未报告。

主要发现

  • 炎症细胞的存在是不稳定动脉粥样硬化斑块的标志。
  • 注射18F-氟脱氧葡萄糖(FDG)的PET成像目前是评估动脉粥样硬化斑块活化巨噬细胞密度最广泛使用的成像技术。
  • FDG-PET成像存在后勤和技术限制,是更广泛用于动脉粥样硬化患者评估的重要障碍。
  • 与肿瘤领域类似,心血管疾病患者中新药的获益与成本平衡需要改善。
  • 斑块炎症PET成像可能是识别最可能从抗炎治疗中获益的患者、并排除其他炎症原因且最可能在这些药物下发生严重副作用的患者的有用工具。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The presence of inflammatory cells is a hallmark of unstable atherosclerotic plaques. Several imaging approaches have been developed for the noninvasive detection of inflammatory activities in atherosclerotic plaques. Positron emission tomography (PET) imaging with the injection of 18F-fluorodeoxyglucose (FDG) is currently the most widely used imaging technique to evaluate the density of activated macrophages in atherosclerotic plaques. Nevertheless, FDG-PET imaging has logistical and technical constraints that represent an important obstacle to the wider use of this approach for the evaluation of patients with atherosclerosis. In a similar way as in the oncological field, the balance between the benefits and costs of new drugs need to be improved in patients with cardiovascular diseases. PET imaging of plaque inflammation might represent a very useful tool to identify patients who could benefit the most from anti-inflammatory treatments and to exclude patients with other causes of inflammation who are the most likely to develop severe side effects under these drugs. The availability of radiotracers targeting more specifically inflammation in atherosclerotic plaques would greatly facilitate the logistic organization of this imaging and help to expand the use of PET for the evaluation of atherosclerotic patients.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Hyafil F, Vigne J. Imaging inflammation in atherosclerotic plaques: Just make it easy! J Nucl Cardiol. 2018. PMID: 29700689. doi:10.1007/s12350-018-1289-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。